SHENCY VARUGHESE: Open Payments
NPI 1598207375 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$933 in 16 payments from 13 companies in 2025. Trend: 2023 $962 · 2024 $1,896 · 2025 $933
Food & beverage: $933
| Company | Payments | Amount |
|---|---|---|
| Syndax Pharmaceuticals, Inc. | 2 | $175 |
| Madrigal Pharmaceuticals | 1 | $142 |
| Legend Biotech USA Inc. | 1 | $133 |
| AstraZeneca Pharmaceuticals LP | 2 | $129 |
| PharmaEssentia USA Corporation | 1 | $100 |
| E.R. Squibb & Sons, L.L.C. | 1 | $85 |
| ABBVIE INC. | 2 | $45 |
| Biogen, Inc. | 1 | $24 |
| VIVUS LLC | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
Products named: REZDIFFRA, CARVYKTI, BESREMI, OPDIVO, REVUFORJ, LINZESS, CALQUENCE, ZURZUVAE.
Industry payments across IL — which companies pay providers there.
